AKT-100

N/A

Report date: 2024/06/28 16:56:12
NME

Base Information

Drug NameAKT-100
Drug Alias NameAKT-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor protein p53 modulators
TargetsTumor protein p53
Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAkkadian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAkkadian Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A